Why a Solid COA Is Essential in the Medical Cannabis Industry

A good COA isn’t just a technical sheet. It’s the assurance that what you consume, prescribe, or export meets the highest international standards.

The Bedrocan Case: A Gold Standard in Compliance

We recently reviewed a COA issued by the Dutch Ministry of Health for the Bedrocan 22% THC batch, intended for the pharmaceutical market. This document not only confirms the potency of the product, but also includes:

✅ Precise concentrations of THC (22%) and CBD (<1%)
✅ Microbiological and heavy metal testing
✅ Pesticide and aflatoxin screening
✅ Certification of compliance with GMP and GAP standards
✅ Expiry date, accurate weight, and cultivation origin

A COA like this is a passport into highly regulated markets like Europe—guaranteeing safety, consistency, and transparency.

Why This Matters for LATAM

In Latin America, where the industry is still building its legal and scientific foundations, a robust COA from a reliable lab is what separates a local product from one ready for international export.

It’s also an essential tool for doctors, pharmacists, importers, and regulators—who all need to know exactly what they’re working with.

Bottom Line: COAs Build Trust

At 420 LATAM, we believe the future of medical cannabis in the region depends on meeting global standards. That’s why we work with partners who prioritize traceability, documentation, and uncompromising quality.

💬 Have questions about certifying your products?
🌍 Looking to enter markets like Germany, Switzerland, or the Czech Republic?

👉 Contact us. We’re building a legal, ethical, and world-class cannabis ecosystem.